Tuesday, November 6, 2012
Amgen drug cuts bad cholesterol up to 66 percent in statin patients - trial
LOS ANGELES (Reuters) - Amgen Inc's experimental cholesterol-lowering drug, AMG145, reduced levels of "bad" cholesterol up to 66 percent in patients already taking statin drugs, according to results from a mid-stage trial that were presented on Tuesday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment